A REVIEW OF NATEGLINIDE IN THE MANAGEMENT OF TYPE 2 DIABETES
Shinde Shraddha B.* and Gondkar Shraddha
ABSTRACT
Nateglinide is oral hypoglycemic agent approved for alone use or in
combination with metformin for the treatment of type 2 diabetes
mellitus. Nateglinide is amino acid derivative of D- phenylalanine,
binds to the ATP potassium channels in pancreatic beta cells and
stimulates the secretion of insulin. Approximately one month therapy
is required for decrease in fasting blood glucose level. It lowers
postprandial blood glucose level and also reduces HbA1c level.
Nateglinide is effective at lowering postprandial blood glucose than
metformin, sulfonylureas and thiazolidinediones. It is rapidly and
completely absorbed in small intestine and has high bioavailability. It
is extensively metabolized in liver and excreted in urine and feces.
Keywords: Hypoglycemic agent, diabetes mellitus, nateglinide, metformin, postprandial, HbA1c level.
[Full Text Article]